[1]邓莉莉,邝瑞军,彭艳辉.HDAC抑制剂CG200745促进STZ诱导糖尿病大鼠胰岛β细胞损伤后的再生修复[J].国际内分泌代谢杂志,2021,41(04):332-338.[doi:10.3760/cma.j.cn121383-20200618-06050]
　Deng Lili,Kuang Ruijun,Peng Yanhui..HDAC inhibitor CG200745 promotes regeneration and repair of islet β-cells in STZ-induced diabetic rats[J].International Journal of Endocrinology and Metabolism,2021,41(04):332-338.[doi:10.3760/cma.j.cn121383-20200618-06050]
点击复制

HDAC抑制剂CG200745促进STZ诱导糖尿病大鼠胰岛β细胞损伤后的再生修复()
分享到：

《国际内分泌代谢杂志》[ISSN:1673-4157/CN:12-1383/R]

卷:
41
期数:
2021年04期
页码:
332-338
栏目:
论著
出版日期:
2021-07-20

文章信息/Info

Title:
HDAC inhibitor CG200745 promotes regeneration and repair of islet β-cells in STZ-induced diabetic rats
作者:
邓莉莉; 邝瑞军; 彭艳辉
郴州市第一人民医院北院儿童急危重医学科 423000
Author(s):
Deng Lili;  Kuang Ruijun;  Peng Yanhui.
Department of Pediatric Emergency and Critical Care Medicine, North Hospital of Chenzhou First People's Hospital, Chenzhou 423000, China
关键词:
组蛋白去乙酰化酶抑制剂;  糖尿病;  胰岛β细胞;  磷脂酰肌醇3激酶/蛋白激酶B通路
Keywords:
Histone deacetylase inhibitor;  Diabetes mellitus;  Islet β cells;  Phosphatidylinositol-3-kinase-protein kinase B pathway
DOI:
10.3760/cma.j.cn121383-20200618-06050
摘要:
目的 探讨组蛋白去乙酰化酶(HDAC)抑制剂CG200745对链脲佐菌素(STZ)诱导糖尿病幼鼠胰岛β细胞的作用及其可能的机制。方法 40只Sprauge-Dawley(SD)幼鼠随机分为空白对照组、糖尿病组、CG低剂量组和CG高剂量组,每组各10只。除空白对照组外,其余组幼鼠腹腔注射STZ50 mg/kg建立糖尿病模型。CG低、高剂量组分别腹腔注射CG200745 1.25 mg/(kg·d)和5.0 mg/(kg·d),空白对照组和糖尿病组腹腔注射等量生理盐水。持续给药3周后,测定幼鼠体重、胰腺重量、血糖和血浆胰岛素水平; 苏木精-伊红(HE)染色法检测胰腺病理组织学变化; 免疫组织化学染色检测胰岛素和增殖细胞核抗原(PCNA)表达; 原位末端转移酶标记(TUNEL)染色检测胰岛β细胞凋亡率; 应用蛋白免疫印迹法(Western-blot)检测胰腺组织的组蛋白3(H3)、组蛋白乙酰化H3(Ac-H3)和磷脂酰肌醇3激酶(PI3K)/蛋白激酶B(PKB或Akt)通路蛋白表达水平。结果 与空白对照组相比,糖尿病组幼鼠胰腺组织中胰岛β细胞数量明显减少,且分布不均匀,排列紊乱,体重、胰腺重量和血浆胰岛素水平降低(P均<0.05),胰腺胰岛素、PCNA和Ac-H3/H3表达降低(P均<0.05),血糖水平、胰岛β细胞凋亡率升高(P均<0.05),胰腺磷酸化磷脂酰肌醇3激酶(p-PI3K)/PI3K和磷酸化蛋白激酶B(p-Akt)/Akt蛋白比值降低; 与糖尿病组相比,CG低、高剂量组幼鼠胰岛β细胞数量增多,且分布和排列趋于规整,体重、胰腺重量和血浆胰岛素水平明显升高(P均<0.05),胰腺胰岛素、PCNA和Ac-H3/H3表达升高(P均<0.05),血糖水平、胰岛β细胞凋亡率降低(P均<0.05),胰腺p-PI3K/PI3K和p-Akt/Akt蛋白比值升高。结论 HDAC抑制剂CG200745对糖尿病幼鼠胰岛β细胞具有保护作用。
Abstract:
Objective To investigate the effect of histone deacetylase(HDAC)inhibitor CG200745 on islet β cells in streptozocin(STZ)induced diabetic rats and its possible mechanism.Methods Forty Sprauge-Dawley(SD)juvenile rats were randomly divided into blank control group, diabetes group, CG low-dose group and CG high-dose group, with 10 rats in each group. Except for the blank control group, juvenile rats were intraperitoneally injected with STZ 50 mg/kg to establish the diabetes model. The CG low- and high-dose groups were intraperitoneally injected with CG200745 1.25 mg/(kg·d)and 5.0 mg/(kg·d)respectively, and the blank control group and diabetes group were intraperitoneally injected with the same amount of normal saline. After continuous administration for 3 weeks, the body weight, pancreas weight, blood glucose and plasma insulin levels of young mice were measured; HE staining was used to detect the pathological changes of pancreas; immunohistochemical staining was used to detect the expression of insulin and proliferating cell nuclear antigen(PCNA); TUNEL staining was used to detect islets β-cell apoptosis rate; Western-blot was used to detect the protein expression of histone acetylation(Ac-H3), histone(H3)and phosphoinositide 3-kinase(PI3K)/protein kinase B(Akt)pathway.Results Compared with the blank control group, the number of islet β cells was significantly reduced, the distribution was uneven, the arrangement was disordered, the body mass, pancreas weight and plasma insulin levels were reduced(all P<0.05), the expression of PCNA and Ac-H3/H3 were decreased(all P<0.05), the blood glucose level and the apoptosis rate of islet β cell were increased(all P<0.05), and the protein expression levels of p-PI3K/PI3K and p-Akt/Akt in the pancreas were decreased in the pancreas tissue of the diabetic rats; Compared with diabetes group, the number of islet β cells increased in the juvenile rats of CG low and high dose group, and the distribution and arrangement tended to be regular. The body mass, pancreas weight and plasma insulin level of juvenile rats in CG low- and high-dose groups were significantly increased(all P<0.05), and the expression of pancreatic insulin, PCNA and Ac-H3/H3 increased(all P<0.05), the blood glucose level and the apoptosis rate of islet β cell decreased(all P<0.05), and the protein expression levels of p-PI3K/PI3K and p-Akt/Akt in the pancreas were increased.Conclusion HDAC inhibitor CG200745 may play a protective effect on islet β cells in diabetic young rats.

参考文献/References:

[1] Rahimi Ghiasi M,Mohammadi H,Symonds ME,et al.Efficacy of insulin targeted gene therapy for type 1 diabetes mellitus:a systematic review and meta-analysis of rodent studies[J].Iran J Basic Med Sci,2020,23(4):406-415.DOI:10.22038/ijbms.2020.39470.9359.
[2] Patterson CC,Karuranga S,Salpea P,et al.Worldwide estimates of incidence,prevalence and mortality of type 1 diabetes in children and adolescents:results from the International Diabetes Federation Diabetes Atlas,9th edition[J].Diabetes Res Clin Pract,2019,157:107842.DOI:10.1016/j.diabres.2019.107842.
[3] Lundh M,Galbo T,Poulsen SS,et al.Histone deacetylase 3 inhibition improves glycaemia and insulin secretion in obese diabetic rats[J].Diabetes Obes Metab,2015,17(7):703-707.DOI:10.1111/dom.12470.
[4] Lee E,Lee HA,Kim M,et al.Upregulation of C/EBPβ and TSC2 by an HDAC inhibitor CG200745 protects heart from DOCA-induced hypertrophy[J].Clin Exp Pharmacol Physiol,2019,46(3):226-236.10.1111/1440-1681.13022.
[5] Yang Q,Jiang W,Hou P.Emerging role of PI3K/AKT in tumor-related epigenetic regulation[J].Semin Cancer Biol,2019,59:112-124.DOI:10.1016/j.semcancer.2019.04.001.
[6] Rajashree R,Patil R,Khlokute SD,et al.Effect of Salacia reticulata W.and Clitoria ternatea L.on the cognitive and behavioral changes in the streptozotocin-induced young diabetic rats[J].J Basic Clin Physiol Pharmacol,2017,28(2):107-114.DOI:10.1515/jbcpp-2016-0024.
[7] Khan S,Jena GB.Protective role of sodium butyrate,a HDAC inhibitor on beta-cell proliferation,function and glucose homeostasis through modulation of p38/ERK MAPK and apoptotic pathways:study in juvenile diabetic rat[J].Chem Biol Interact,2014,213:1-12.DOI:10.1016/j.cbi.2014.02.001.
[8] Sabari BR,Zhang D,Allis CD,et al,Metabolic regulation of gene expression through histone acylations[J].Nat Rev Mol Cell Biol,2017,18(2):90-101.DOI:10.1038/nrm.2016.140.
[9] Zhao C,Dong H,Xu Q,et al.Histone deacetylase(HDAC)inhibitors in cancer:a patent review(2017-present)[J].Expert Opin Ther Pat,2020,30(4):263-274.DOI:10.1080/13543776.2020.1725470.
[10] Wu J,Cang S,Liu C,et al.Development of human prostate cancer stem cells involves epigenomic alteration and PI3K/AKT pathway activation[J].Exp Hematol Oncol,2020,9:12.DOI:10.1186/s40164-020-00168-0.
[11] Lee HA,Lee E,Ga YD.Histone deacetylase inhibitor MGCD0103 protects the pancreas from streptozotocin-induced oxidative stress and β-cell death[J].Biomed Pharmacother,2019,109:921-929.DOI:10.1016/j.biopha.2018.10.163.
[12] Xie Y,Shi X,Sheng K,et al.PI3K/Akt signaling transduction pathway,erythropoiesis and glycolysis in hypoxia(Review)[J].Mol Med Rep,2019,19(2):783-791.DOI:10.3892/mmr.2018.9713.
[13] Makkar R,Behl T,Arora S.Role of HDAC inhibitors in diabetes mellitus[J].Curr Res Transl Med,2020,68(2):45-50.DOI:10.1016/j.retram.2019.08.001.
[14] Huang X,Liu G,Guo J,et al.The PI3K/Akt pathway in obesity and type 2 diabetes[J].Int J Biol Sci,2018,14(11):1483-1496.DOI:10.7150/ijbs.27173.
[15] Du LJ,Pang B,Tan YM,et al.Banxia xiexin decoction ameliorates t-BHP-induced apoptosis in pancreatic beta cells by activating the PI3K/AKT/FOXO1 signaling pathway[J].J Diabetes Res,2020,2020:3695689.DOI:10.1155/2020/3695689.
[16] Remsberg JR,Ediger BN,Ho WY,et al.Deletion of histone deacetylase 3 in adult beta cells improves glucose tolerance via increased insulin secretion[J].Mol Metab,2016,6(1):30-37.DOI:10.1016/j.molmet.2016.11.007.
[17] Di W,Yuqian Y,Ting W,et al.An acetyl-histone vulnerability in PI3K/AKT inhibition-resistant cancers is targetable by both BET and HDAC inhibitors[J].Cell Rep,2021,34(7):108744.DOI:10.1016/j.celrep.2021.108744.
[18] Hussain N, Chuang SJ,Johanns M,et al.Effects of PKB/AKT inhibitors on insulin-stimulated lipogenesis and phosphorylation state of lipogenic enzymes in white adipose tissue[J].Biochem J,2020,477(8):1373-1389.DOI:10.1042/BCJ20190788.

相似文献/References:

[1]李春睿,王静,陈峰,等.GLP-1受体激动剂对糖尿病患者肾功能的影响[J].国际内分泌代谢杂志,2014,(06):401.[doi:10.3760/cma.j.issn.1673-4157.2014.06.011]
　Li Chunrui*,Wang Jing,Chen Feng,et al.Effects of GLP-1 receptor agonists on renal function of diabetics[J].International Journal of Endocrinology and Metabolism,2014,(04):401.[doi:10.3760/cma.j.issn.1673-4157.2014.06.011]
[2]黄珊珊,鲁一兵.长链非编码RNA与糖尿病[J].国际内分泌代谢杂志,2015,(04):271.[doi:10.3760/cma.j.issn.1673-4157.2015.04.016]
　Huang Shanshan*,Lu Yibing..Long non-coding RNA and diabetes mellitus[J].International Journal of Endocrinology and Metabolism,2015,(04):271.[doi:10.3760/cma.j.issn.1673-4157.2015.04.016]
[3]高瑞霄,姚朱华,冯凭,等.尿8-羟基脱氧鸟苷在2型糖尿病及糖尿病合并冠心病患者中的临床意义[J].国际内分泌代谢杂志,2014,(05):295.[doi:10.3760/cma.j.issn.1673-4157.2014.05.002]
　Gao Ruixiao*,Yao Zhuhua,Feng Ping,et al.The clinical significance of urinary 8-hydroxy deoxyguanosine in patients with type 2 diabetes mellitus and diabetic patients with coronary heart disease[J].International Journal of Endocrinology and Metabolism,2014,(04):295.[doi:10.3760/cma.j.issn.1673-4157.2014.05.002]
[4]郑佳,肖新华.葡萄糖稳态的中枢调控作用机制 ——2014年美国糖尿病协会“杰出科学成就奖” 演讲报告解读[J].国际内分泌代谢杂志,2014,(05):305.[doi:10.3760/cma.j.issn.1673-4157.2014.05.004]
　Zheng Jia,Xiao Xinhua.The mechanisms of central nervous system in the control of glucose homeostasis--A summary of 2014 ADA "Outstanding Scientific Achievement Award" Lecture[J].International Journal of Endocrinology and Metabolism,2014,(04):305.[doi:10.3760/cma.j.issn.1673-4157.2014.05.004]
[5]唐勤,邵莉.蛋白乙酰化与胰岛素分泌[J].国际内分泌代谢杂志,2014,(05):313.[doi:10.3760/cma.j.issn.1673-4157.2014.05.007]
　Tang Qin,Shao Li..Protein acetylation and insulin secretion[J].International Journal of Endocrinology and Metabolism,2014,(04):313.[doi:10.3760/cma.j.issn.1673-4157.2014.05.007]
[6]卢婷婷,任思佳,沈捷.人群迁徙对糖尿病患病率的影响及其相关因素[J].国际内分泌代谢杂志,2014,(05):327.[doi:10.3760/cma.j.issn.1673-4157.2014.05.011]
　Lu Tingting,Ren Sijia,Shen Jie..Impact of migration on prevalence of diabetes and risk factors[J].International Journal of Endocrinology and Metabolism,2014,(04):327.[doi:10.3760/cma.j.issn.1673-4157.2014.05.011]
[7]包薇萍,陈国芳,刘超.DPP-4抑制剂的肾保护作用[J].国际内分泌代谢杂志,2014,(05):337.[doi:10.3760/cma.j.issn.1673-4157.2014.05.014]
　Bao Weiping,Chen Guofang,Liu Chao..Renal protective effects of dipeptidyl peptidase-4 inhibitors[J].International Journal of Endocrinology and Metabolism,2014,(04):337.[doi:10.3760/cma.j.issn.1673-4157.2014.05.014]
[8]孟庆冬,陶红.巨噬细胞凋亡与糖尿病动脉粥样硬化[J].国际内分泌代谢杂志,2014,(05):340.[doi:10.3760/cma.j.issn.1673-4157.2014.05.015]
　Meng Qingdong,Tao Hong..Macrophage apoptosis and diabetic atherosclerosis[J].International Journal of Endocrinology and Metabolism,2014,(04):340.[doi:10.3760/cma.j.issn.1673-4157.2014.05.015]
[9]赵荷珺 洪天配.胰高血糖素样肽-1类药物与胰腺安全性[J].国际内分泌代谢杂志,2015,(05):319.[doi:DOI:10.3760/cma.j.issn.1673-4157.2015.05.008]
　Zhao Hejun*,Hong Tianpei..Glucagon-like peptide-1-based therapies and pancreatic safety[J].International Journal of Endocrinology and Metabolism,2015,(04):319.[doi:DOI:10.3760/cma.j.issn.1673-4157.2015.05.008]
[10]吕丹 李晓思 陈树春 王泽普.Betatrophin:糖尿病再生治疗的新希望[J].国际内分泌代谢杂志,2015,(05):351.[doi:DOI:10.3760/cma.j.issn.1673-4157.2015.05.016]
　Lyu Dan*,Li Xiaosi,Chen Shuchun,et al.Betatrophin:new hope for regeneration therapy of diabetes[J].International Journal of Endocrinology and Metabolism,2015,(04):351.[doi:DOI:10.3760/cma.j.issn.1673-4157.2015.05.016]

备注/Memo

备注/Memo:
通信作者:邓莉莉,Email:dd01320@163.com
更新日期/Last Update: 1900-01-01